Found 698 clinical trials
DWIBS-MRI: An Adjunct to the Traditional Diagnostic Breast Imaging Evaluation
- 0 views
- 19 Feb, 2024
Observational Study in Diagnosed Patients COVID-19 Supported on an Outpatient Basis. (COVID-PSL)
- 0 views
- 19 Feb, 2024
Prognostic Factors of COVID19
The primary purpose of the "COVID-HUS" protocol is to investigate viral and host-related factors to understand the pathophysiology of COVID infection and to open the way for new diagnostic, prognostic and therapeutic strategies against SARS CoV-2 .
The secondary objectives are
<ul>- 0 views
- 19 Feb, 2024
Layer-specific Contribution to Consolidation of Skill Learning in the Primary Motor Cortex
- Design
Participants will be screened with:
<ul>Participants may have 2 magnetic resonance imaging (MRI) scans of the brain.
- 0 views
- 19 Feb, 2024
Kinematic Assessment In Multiple Sclerosis
The overall aim of this study is to use established kinematic assessment tools to explore the extent and progression of upper limb dysfunction in patients with progressive MS. This aim will be achieved via the following objectives:
<ul>- 0 views
- 19 Feb, 2024
reatment Standards and Outcomes of Patients With ER/PR Positive HER2-negative Metastatic Breast Cancer
To capture the treatment patterns and clinical characteristics of patients with ER/PR positive, HER2-negative MBC in Greece
- 0 views
- 19 Feb, 2024
Attentional Performance in Parkinson Disease
Background Parkinson Disease (PD) is a nervous system disorder that affects movement. Dopamine is an important neurotransmitter in the brain. As PD progresses, there is less and less dopamine in the brain. Researchers think there may be a relationship between differences in attention and dopamine in people with PD. Objective …
- 0 views
- 19 Feb, 2024
Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method
Prospective assay for SARS-CoV-2 antibody detection indirectly by immunofluorescence: SARS-CoV2 IIF method
- 0 views
- 19 Feb, 2024
Bringing of PET-TDM FDG in the Determination of the Characteristics of Primary Mammary Tumors TrIple Negatives
"Triple Negative" breast cancers are a heterogeneous group characterized by the absence of hormone receptors to estrogen, progesterone and the absence of expression or amplification of the HER-2 gene. This type of cancer is associated with an adverse clinical profile with a high risk of early metastatic relapse. Accurate identification …
- 0 views
- 19 Feb, 2024